| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $272.75M | $258.30M | $224.75M | $283.39M | $329.50M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $228.21M | $218.84M | $198.52M | $253.28M | $244.57M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $9.37M | $8.39M | $4.54M | $6.21M | $17.91M |
| Net Income | $35.18M | $31.07M | $21.69M | $23.90M | $67.02M |
| EPS (basic) | 18.6400 | 16.4800 | 11.4500 | 12.6000 | 35.3800 |
| EPS (diluted) | 18.5700 | 16.4300 | 11.4500 | 12.5900 | 35.2800 |
| Shares (diluted) | $1.90M | $1.89M | $1.89M | $1.90M | $1.90M |